Kane Biotech Announces Canadian Distribution Agreement With Best Buy Medical for revyve™ Antimicrobial Wound Gel
11 mars 2025 08h30 HE
|
Kane Biotech Inc.
WINNIPEG, Manitoba, March 11, 2025 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE OTCQB:KNBIF) (“Kane Biotech”) announces that it has concluded a three-year distribution agreement with Best Buy...
CytoSorbents to Report Fourth Quarter and Full Year 2024 Financial Results and Recent Business Highlights
26 févr. 2025 07h00 HE
|
CytoSorbents
CytoSorbents Announces Fourth Quarter and Full Year 2024 Earnings Release Date for March 6, 2025
CytoSorbents Further Strengthens Balance Sheet with Exercise of Previously Announced Series A Right Warrants
25 févr. 2025 07h00 HE
|
CytoSorbents
CytoSorbents Strengthens Balance Sheet with Additional $1.6M in Aggregate Gross Proceeds from Shareholder Exercise of Series A Right Warrant
CytoSorbents Reports Preliminary Unaudited Fourth Quarter and Full-Year 2024 Product Revenue
03 janv. 2025 07h00 HE
|
CytoSorbents
CytoSorbents' Preliminary Unaudited Q4 2024 Product Revenue Increased 22-25% From A Year Ago With Product Gross Margins Of ~70%
Nutriterra® Total Omega-3 Receives Health Canada Approval as Plant-Based Dietary Supplement
11 déc. 2024 12h47 HE
|
Nufarm
Nutriterra® Total Omega-3 Receives Health Canada Approval as Plant-Based Dietary Supplement. This groundbreaking ingredient delivers DHA through canola.
Kane Biotech Announces Health Canada Approval of revyve™ Antimicrobial Wound Gel
14 nov. 2024 13h10 HE
|
Kane Biotech Inc.
WINNIPEG, Manitoba, Nov. 14, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (the “Company” or “Kane Biotech”) announces today that it has received Health Canada approval of its...
CytoSorbents Reports Third Quarter 2024 Financial and Operational Results
07 nov. 2024 16h05 HE
|
CytoSorbents
PRINCETON, N.J., Nov. 07, 2024 (GLOBE NEWSWIRE) -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery...
bioLytical Laboratories Inc. Announces Health Canada Authorization of its rapid INSTI® HCV Antibody Test for Professional Use in Canada
04 nov. 2024 12h00 HE
|
bioLytical Laboratories Inc.
bioLytical Laboratories Inc. announced today the immediate availability of its INSTI® HCV Antibody Test in the Canadian market
CytoSorbents Submits Health Canada Medical Device License Application for DrugSorb-ATR Following MDSAP Certification
04 nov. 2024 07h00 HE
|
CytoSorbents
CytoSorbents submits DrugSorb-ATR Medical Device License Application to Health Canada following MDSAP Certification. Expects regulatory decision in 2025
Quality Smart Solutions Launches GRAS Experts to Protect Against Food Safety Risks
25 oct. 2024 12h24 HE
|
Quality Smart Solutions Inc.
TORONTO, Oct. 25, 2024 (GLOBE NEWSWIRE) -- In light of McDonald’s recent recall of Quarter Pounders due to E. coli contamination, the need for stringent oversight on food ingredients has never been...